Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (331-340 of 636) with videos related to

Pageof 64
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2021
Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed AlgorithmNilay Danis, Sharon R Weeks, Ahyoung Kim, et al.
Abdominal Radiology (New York)|August 22, 2018
Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitisJonathan C Hooker, Gavin Hamilton, Charlie C Park, et al.
Metabolism: Clinical and Experimental|August 7, 2013
Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosisNicole E Jensky, Matthew A Allison, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitisRohit Loomba, Peter Chen-Yang Nikhil Daniel, Youxin Wang, et al.
Hepatology (Baltimore, Md.)|May 13, 2025
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyRohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2024
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver diseaseSimon Schophaus, Kate Townsend Creasy, Paul-Henry Koop, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 19, 2013
Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRIBenjamin L Johnson, Michael E Schroeder, Tanya Wolfson, et al.
WFUMB Ultrasound Open|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLDMohammad Honarvar, Julio Lobo, Caitlin Schneider, et al.
American Journal of Preventive Cardiology|October 29, 2025
The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virusRichard K Sterling, Alice L Sternberg, Jordan E Lake, et al.
Pageof 64

Showing results (331-340 of 636) with videos related to

Sort By:
Pageof 64
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2021
Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed AlgorithmNilay Danis, Sharon R Weeks, Ahyoung Kim, et al.
Abdominal Radiology (New York)|August 22, 2018
Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitisJonathan C Hooker, Gavin Hamilton, Charlie C Park, et al.
Metabolism: Clinical and Experimental|August 7, 2013
Null association between abdominal muscle and calcified atherosclerosis in community-living persons without clinical cardiovascular disease: the multi-ethnic study of atherosclerosisNicole E Jensky, Matthew A Allison, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitisRohit Loomba, Peter Chen-Yang Nikhil Daniel, Youxin Wang, et al.
Hepatology (Baltimore, Md.)|May 13, 2025
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyRohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2024
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver diseaseSimon Schophaus, Kate Townsend Creasy, Paul-Henry Koop, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 19, 2013
Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRIBenjamin L Johnson, Michael E Schroeder, Tanya Wolfson, et al.
WFUMB Ultrasound Open|May 26, 2025
Methods and Validation of Velacur Determined Fat Fraction in patients with MASLDMohammad Honarvar, Julio Lobo, Caitlin Schneider, et al.
American Journal of Preventive Cardiology|October 29, 2025
The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virusRichard K Sterling, Alice L Sternberg, Jordan E Lake, et al.
Pageof 64